GLI1 and gastrointestinal stromal tumor: Thus, simultaneous pharmacologic inhibition of GLI1 and GLI2 decreased KIT mRNA expression in both imatinib-sensitive and imatinib-resistant GIST [34, 35], similarly to genetic silencing of GLI1 and GLI2 in GIST882 cells (Figure 4C).